General Information of the Compound
Compound ID
CP0073619
Compound Name
2-(4,6-bis(dimethylamino)-2-(4-(4-(trifluoromethyl)benzamido)benzyl)pyrimidin-5-yl)acetic acid
    Show/Hide
Synonyms
AP-761
BI-671800
    Show/Hide
Structure
Formula
C25H26F3N5O3
Molecular Weight
501.509
Canonical SMILES
CN(C)c1nc(Cc2ccc(NC(=O)c3ccc(cc3)C(F)(F)F)cc2)nc(N(C)C)c1CC(O)=O
    Show/Hide
InChI
InChI=1S/C25H26F3N5O3/c1-32(2)22-19(14-21(34)35)23(33(3)4)31-20(30-22)13-15-5-11-18(12-6-15)29-24(36)16-7-9-17(10-8-16)25(26,27)28/h5-12H,13-14H2,1-4H3,(H,29,36)(H,34,35)
    Show/Hide
InChIKey
XEOSTBFUCNZKGS-UHFFFAOYSA-N
CAS
1093108-50-9
Physicochemical Property
logP
4.0976
Rotatable Bonds
8
Heavy Atom Count
36
Polar Areas
98.66
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
6
Complexity
36

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 45270144
SID: 99235621
ChEMBL ID
CHEMBL551813
DrugBank ID
DB12524
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02279, Prostacyclin receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( AP-761 )
Drug Name AP-761
Company Actimis Pharmaceuticals Inc
Indication
Asthma
Phase 2
Target(s)
Prostaglandin D2 receptor 2 (PTGDR2)
Antagonist